Doctor profile · Federal record
Dr. Jake Turrentine, MD
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Dermatology Physician · Dermatology Physician · Dermatology Physician · Hickory, NC
- NPI 1386934933
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 15 yrs in practice
- Licensed in 5 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1899 Tate Blvd Se Ste 2110
Hickory, NC 286024200
(828) 328-4449
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- November 2, 2017
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (5)
- North Carolina #2016-02183 · Georgia #072838 · Florida #ME121327 · South Carolina #37485 · Texas #P8091
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1386934933. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
19,193
Distinct HCPCS
10
Medicare allowed
$1,274,421
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3245 |
Injection, tildrakizumab, 1 mg | 5,000 | 13 | $138 | |
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 4,200 | 14 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,553 | 415 | $6 | |
95044 |
Test for allergy using skin patch | 1,805 | 22 | $4 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,477 | 1,003 | $85 | |
11102 |
Biopsy of related skin growth, first growth | 824 | 608 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 704 | 529 | $45 | |
11103 |
Biopsy of related skin growth, each additional growth | 515 | 259 | $47 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 398 | 313 | $284 | |
17110 |
Destruction of skin growth, 1-14 growths | 305 | 263 | $104 |
In context: peer comparison
Among 3 peers in Hickory Dermatology Physician, average services per provider: 420. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$11,347
Transactions
30
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | 7 | $10,809.28 | |
| Abbvie INC. | 11 | $147.56 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $110.97 | |
| Janssen Biotech, INC. | 2 | $104.20 | |
| Leo Pharma INC. | 2 | $53.76 | |
| Ucb, INC. | 1 | $41.37 | |
| Genzyme Corporation | 1 | $40.89 | |
| Novartis Pharmaceuticals Corporation | 1 | $21.33 | |
| Galderma Laboratories, L.P. | 1 | $18.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,442
Patients
953
Total drug cost
$51,310
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 267 | 165 | $7,806 |
| Clobetasol Propionate | Generic | 257 | 167 | $14,582 |
| Ketoconazole | Generic | 199 | 122 | $4,650 |
| Triamcinolone Acetonide | Generic | 174 | 128 | $2,045 |
| Mupirocin | Generic | 77 | 67 | $683 |
| Hydrocortisone | Generic | 72 | 57 | $617 |
| Metronidazole | Generic | 69 | 49 | $5,253 |
| Fluorouracil | Generic | 51 | 49 | $5,542 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 51 | 22 | $1,746 |
| Methotrexate (Methotrexate Sodium) | Brand | 47 | 12 | $445 |
Frequently asked questions
What is Dr. Jake Turrentine's medical specialty?
Dr. Jake Turrentine practices Dermatology Physician in Hickory, NC.
Where does Dr. Jake Turrentine practice?
Dr. Jake Turrentine practices at 1899 Tate Blvd Se Ste 2110, Hickory, NC 286024200. Office phone: 8283284449.
What is Dr. Jake Turrentine's NPI?
Dr. Jake Turrentine's National Provider Identifier (NPI) is 1386934933, issued by NPPES.
Does Dr. Jake Turrentine accept Medicare assignment?
Yes. Dr. Jake Turrentine accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jake Turrentine commonly perform?
Top Medicare-reported procedures in 2023: Injection, tildrakizumab, 1 mg (HCPCS J3245); Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.